• A
  • A
  • A

Message from the Dean

Kenneth Kaushansky, MDRenaissance School of Medicine at Stony Brook University is Long Island’s premier medical school and teaching site for Stony Brook Medicine, Long Island’s leading academic medical center.

The top-ranked public medical school in New York State, Renaissance School of Medicine trains the next generation of committed, curious and highly capable physicians, advances our understanding of the origins of human health and disease, and delivers world-class, compassionate healthcare.

Renaissance is part of Stony Brook University, one of 62 members of the Association of American Universities (AAU), the invitation-only organization of the best research universities in North America. We conduct more than $90 million in annual research, bringing the best ideas in medicine from the research laboratory to the bedside to benefit patients at Stony Brook Medicine and across the globe.

Renaissance provides 64 accredited residency and fellowship programs with 738 residents (666 medical and 72 dental residents). Our residents and fellows train in various specialties across five main care sites:

  • Stony Brook University Hospital
  • Stony Brook Children’s Hospital
  • Stony Brook Southampton Hospital
  • Stony Brook Eastern Long Island Hospital
  • Northport VA Medical Center
  • Nassau University Medical Center

In 2016, we entered a strategic partnership with Mount Sinai Health System and the Icahn School of Medicine in Manhattan for collaborative education, research and clinical care programs.

Renaissance is the home of major healthcare innovations by Stony Brook researchers, including:

  • Development of the Nobel Prize-winning technology that led to the MRI
  • Assisting in development of the technology for PET scans
  • Development of the technology for 3D virtual colonoscopy
  • Discovery of the cause of Lyme disease

Our researchers have developed groundbreaking new medications, including:

  • ReoPro® (a drug used for cardiac angioplasty)
  • Periostat® (a drug used for periodontal disease)
  • Xiaflex® (a drug used to treat Dupuytren’s disease)

The new name of our medical school commemorates a transformative relationship with more than 100 families of Renaissance Technologies, who have propelled academic and professional excellence and innovation across Stony Brook University’s campus and beyond for more than 35 years.

Starting with a gift made 35 years ago by Jim Simons, former Stony Brook Math Department Chair – who incubated the company on the Stony Brook University campus – this relationship has resulted in more than $500 million donated by 111 Renaissance families, creating a vital catalyst for our trajectory of innovation and excellence to benefit Stony Brook’s students, faculty, patients and community.

We invite you to learn more here about Long Island’s premier medical school and teaching hospital, and our innovative medical education, leading-edge clinical research and groundbreaking medical care.

 

Kenneth Kaushansky, MD
Senior Vice President, Health Sciences
Dean, Renaissance School of Medicine at Stony Brook University